« Back to the previous page

Also available in: Deutsch

Pharmaceutical applications manufacturer Western Europe for sale

Pharmaceutical applications manufacturer Western Europe for sale

  • Sales: >2M EUR
  • Investment required: >5M EUR
  • Location of the company: Europe
  • Reason for sale: The owners of this distributor are looking for a strategic buyer to support with the further growth of the company
  • #CFIE PHS007

Overview of this pharmaceutical applications manufacturer Western Europe for sale

The management of a pharmaceutical applications company is looking for investor to finance further growth in exchange for a stake in the capital in the company. This company is a potential leader in its market niche and plans to gain a recognizable market position in its sector in the coming years. They started development of the technology 5 years ago and it has already developed it to a viable commercial solution.

Approximately 4 years ago, the company raised capital of 5M EUR from North American investment fund, which allowed the company to research and develop the current solution. Currently, the company launched second investment round and is looking for suited investors which would help and enable full commercialization of its technology and turnover growth.

Profile of this pharmaceutical applications manufacturer Western Europe for sale

The company for sale is a young and dynamic company, focused on recombinant protein expression technology. The company holds an already validated, protected and awarded technology allowing for substantial improvement in levels of recombinant protein production.

Recombinant human proteins, which are the key functional component in a wide array of pharmaceutical products and applications, hold a large potential as the market has already a multibillion dollar potential. Commercialization of the products is executed through an innovative licensing model, mitigating risks and maximizing return for the company.

He company headquarters are located in the Western Europe, but an office aimed at business development has already been established in the U.S., successfully operating ever since. The company has a team of more than 15 experienced and dedicated people – the team is constantly growing. The company has already established successful partnerships with big pharma and biotech companies.

Potential investor with his investment will gain:
  • Strong revenue growth potential
  • Only moderately risky investment
  • Patented and proven technology
  • Experienced management 
The new owners can enter the company via a share acquisition or a capital increase. 

Buy this pharmaceutical
applications manufacturer

Contact us to get details about this pharmaceutical applications manufacturer in Western Europe for sale

Products and services of this pharmaceutical applications manufacturer Western Europe for sale

The company has developed a novel technology for improved production of complex, human proteins for pharmaceutical applications. This innovative process results in significant yield increases and production cost savings. The technology is highly suitable for production of biosimilars, the follow-on versions of original biological medicines, for which cost efficiency is essential in development and commercialization. The process also allows production of difficult proteins at commercially viable levels.

The client portfolio of the company includes mainly:

  • Big Pharma companies
  • Biotech oriented companies
  • Biosimilar producers
  • Contract manufacturers

The business plan of the company projects the turnover of the company to soar and reach more than 15 M EUR per year after full commercialization though license provision in 5 years timespan. The profitability (EBITDA) should reach 60 – 75% of the turnover. The risk of lowering revenues is minimized by licenses paid upfront strategy - clients are granted a (multi) product license without any royalty obligation.

Highlights of this pharmaceutical applications manufacturer

  • The company holds an awarded and patented technology resulting in yield increases and production cost savings for its clients
  • The company has already raised capital of almost 5M EUR in first investment round
  • The company now needs investors willing to raise capital for full commercialization of the current, already developed technology

Information of this pharmaceutical applications manufacturer 

Please feel free to ask for more information about this pharmaceutical applications manufacturer in Western Europe for sale. If this company does not match your preferences, ask for our other pharmaceutical companies open for a sale. We know the pharmaceutical industry. If you are looking for other pharmaceutical business for sale, please visit the section pharmaceutical companies for sale. If you are looking to sell your pharmaceutical business or you know about the pharmaceutical company for sale, please visit the section pharmaceutical companies wanted.